Article
Adam J. Fein, PhD, of Pembroke Consulting and Drug Channels, appeared on FOX Business to discuss the recent partnership between Walgreens, Alliance Boots, and AmerisourceBergen.
Adam J. Fein, PhD, of Pembroke Consulting and Drug Channels, appeared on FOX Business to discuss the recent partnership between Walgreens, Alliance Boots, and AmerisourceBergen.
He noted that the future of our health is going to be in biological products. The pharmaceutical industry’s focus, he said, will be in treatments for chronic diseases like cancer and multiple sclerosis.
“Within a few years, 50% of all the pharmaceutical industry’s revenues are going to come from these specialty drugs that target very specific diseases,” noted Dr. Fein.
Watch the video below to see the whole segment.
Watch the latest video at <a href="http://video.foxbusiness.com">video.foxbusiness.com</a>
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa